908 Devices Announces Pricing of Public Offering
11 11월 2021 - 9:40AM
Business Wire
908 Devices Inc. (NASDAQ: MASS), a pioneer of purpose-built
handheld and desktop mass spec devices for chemical and
biomolecular analysis, today announced the pricing of a public
offering of shares of its common stock, with 3,150,000 shares being
offered by the Company at a public offering price of $32.00 per
share. In addition, 908 Devices has granted the underwriters a
30-day option to purchase up to an additional 472,500 shares of
common stock from the Company. The gross proceeds from the
offering, before deducting underwriting discounts and commissions
and offering expenses payable by 908 Devices, are expected to be
approximately $100.8 million, excluding any exercise of the
underwriters’ option to purchase additional shares. The offering is
expected to close on November 15, 2021, subject to the satisfaction
of customary closing conditions.
The Company intends to use the net proceeds from the offering,
together with its existing cash and cash equivalents, for working
capital and general corporate purposes, including: (1) to fund its
research and development efforts to expand the applications of its
current devices and to create enhanced products with its platform
of technologies; (2) to expand its commercial operations and
accelerate planned investments; and (3) to acquire complementary
businesses, products, services or technologies.
Cowen and SVB Leerink are acting as lead book-running managers
for the offering. William Blair and Stifel are book-running
managers for the offering.
A registration statement on Form S-1 relating to the shares sold
in the public offering has been filed with the Securities and
Exchange Commission and became effective on November 10, 2021. The
offering will be made only by means of a prospectus, copies of
which may be obtained from: Cowen and Company, LLC, c/o Broadridge
Financial Solutions, Attention: Prospectus Department, 1155 Long
Island Avenue, Edgewood, NY 11717, by telephone at 833-297-2926, or
by email at PostSaleManualRequests@broadridge.com; or SVB Leerink
LLC, Attention: Syndicate Department, 53 State Street, 40th Floor,
Boston, Massachusetts 02109, telephone: 1-800-808-7525, ext. 6105,
or by email at syndicate@svbleerink.com.
This press release shall not constitute an offer to sell or a
solicitation of an offer to buy, nor shall there be any sale of,
these securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or
jurisdiction
About 908 Devices
908 Devices is democratizing laboratory mass spectrometry with
its simple handheld and desktop devices, addressing
critical-to-life applications. The Company’s devices are used at
the point-of-need to interrogate unknown and invisible materials
and provide quick, actionable answers to directly address some of
the most critical problems in life sciences research,
bioprocessing, pharma / biopharma, forensics and adjacent markets.
The Company is headquartered in the heart of Boston, where it
conducts research, designs and manufactures innovative products
that bring together the power of mass spectrometry, microfluidic
separations, software automation, and machine learning.
Forward Looking Statements
This press release includes “forward looking information,”
including with respect to the timing of the public offering and our
intended use of proceeds. Words or phrases such as “will,”
“believes,” “intends” or “expects” or similar expressions are
intended to identify forward-looking statements. Forward-looking
statements involve known and unknown risks, uncertainties and
assumptions. These and other risks and uncertainties are described
in greater detail in the section entitled “Risk Factors” in the
preliminary prospectus and the Company’s most recent annual report
on Form 10-K and quarterly report on Form 10-Q as filed with the
SEC, as well as discussions of potential risks, uncertainties, and
other important factors in the Company’s other filings with the
SEC, including those contained or incorporated by reference in the
preliminary prospectus related to the public offering as filed with
the SEC. These risks and uncertainties may cause actual results to
differ materially from any results expressed or implied by any
forward-looking statement. Although the Company believes that the
expectations reflected in its forward-looking statements are
reasonable, it cannot guarantee future results. The Company has no
obligation, and does not undertake any obligation, to update or
revise any forward-looking statement made in this press release to
reflect changes since the date of this press release, except as
required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211110006470/en/
Investor Contact: Carrie Mendivil IR@908devices.com
908 Devices (NASDAQ:MASS)
과거 데이터 주식 차트
부터 7월(7) 2024 으로 8월(8) 2024
908 Devices (NASDAQ:MASS)
과거 데이터 주식 차트
부터 8월(8) 2023 으로 8월(8) 2024